Timing and Patterns of Relapse‐Related Events Following Adjuvant <scp>CDK4</scp> /6 Inhibitors Combined With Endocrine Therapy in Patients With <scp>HR</scp> ‐Positive, <scp>HER2</scp> ‐Negative Early Breast Cancer
- DOI
- 10.1002/cam4.72224
- Published
- 2026-08
- Container
- Cancer Medicine
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.72224,
title = {Timing and Patterns of Relapse‐Related Events Following Adjuvant
<scp>CDK4</scp>
/6 Inhibitors Combined With Endocrine Therapy in Patients With
<scp>HR</scp>
‐Positive,
<scp>HER2</scp>
‐Negative Early Breast Cancer},
author = {Huihui Chen and Shijie Wu and Yangyang Shan and Xianan Guo and Wei Lu and Yiding Chen and Yunxiang Zhou},
year = {2026},
journal = {Cancer Medicine},
doi = {10.1002/cam4.72224},
url = {https://doi.org/10.1002/cam4.72224}
}RIS
TY - JOUR
TI - Timing and Patterns of Relapse‐Related Events Following Adjuvant
<scp>CDK4</scp>
/6 Inhibitors Combined With Endocrine Therapy in Patients With
<scp>HR</scp>
‐Positive,
<scp>HER2</scp>
‐Negative Early Breast Cancer
AU - Huihui Chen
AU - Shijie Wu
AU - Yangyang Shan
AU - Xianan Guo
AU - Wei Lu
AU - Yiding Chen
AU - Yunxiang Zhou
PY - 2026
JO - Cancer Medicine
DO - 10.1002/cam4.72224
UR - https://doi.org/10.1002/cam4.72224
ER - APA
Chen, H., Wu, S., Shan, Y., Guo, X., Lu, W., Chen, Y., & Zhou, Y. (2026). Timing and Patterns of Relapse‐Related Events Following Adjuvant <scp>CDK4</scp> /6 Inhibitors Combined With Endocrine Therapy in Patients With <scp>HR</scp> ‐Positive, <scp>HER2</scp> ‐Negative Early Breast Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.72224
Source records
- crossref · retrieved 2026-09-27T04:29:11.419Z